Author

Dana Ashoor

Observed names: Ashoor, Dana, Dana N Ashoor, Dana N. Ashoor

Institution: Arabian Gulf University

Observed institution: Arabian Gulf University

ORCID: 0000-0002-0376-6859

Observed ORCID: 0000-0002-0376-6859

OpenAlex ID: A5030385185

A Computational Approach to Evaluate the Combined Effect of SARS-CoV-2 RBD Mutations and ACE2 Receptor Genetic Variants on Infectivity: The COVID-19 Host-Pathogen Nexus

2021 · Dana Ashoor, Noureddine Ben Khalaf, et al. · Frontiers in Cellular and Infection Microbiology · 17

Engineering of the upper hinge region of human IgG1 Fc enhances the binding affinity to FcγIIIa (CD16a) receptor isoform

2018 · Dana N Ashoor, Noureddine Ben Khalaf, et al. · Protein Engineering Design and Selection · 12

Genetic variants of the EGFR ligand-binding domain and their association with structural alterations in Arab cancer patients

2021 · Maryam Marzouq, Ali Nairouz, et al. · BMC Research Notes · 4

In silico evaluation of anti SARS-CoV-2 antibodies neutralization power: A blueprint with monoclonal antibody Sotrovimab

2023 · Dana Ashoor, Maryam Marzouq, et al. · Research Square · 3

How concerning is a SARS-CoV-2 variant of concern? Computational predictions and the variants labeling system

2022 · Dana Ashoor, Maryam Marzouq, et al. · Frontiers in Cellular and Infection Microbiology · 3

Comparison of the Neutralization Power of Sotrovimab Against SARS-CoV-2 Variants: Development of a Rapid Computational Method

2024 · Dana Ashoor, Maryam Marzouq, et al. · JMIR Bioinformatics and Biotechnology · 1

A novel approach to designing viral precision vaccines applied to SARS-CoV-2

2024 · Khaled Trabelsi, Noureddin Ben Khalaf, et al. · Frontiers in Cellular and Infection Microbiology · 1

In silico evaluation of ten monoclonal antibodies neutralization power of SARS-CoV-2 variants EG.5, BA.2.86 and JN.1 (Preprint)

2024 · Dana Ashoor

In Silico Evaluation of Ten Monoclonal Antibodies Neutralization Power of SARS-CoV-2 Variants EG.5, BA.2.86 and JN.1

2024 · Dana N. Ashoor · Preprints.org

In silico evaluation of ten monoclonal antibodies neutralization power of SARS-CoV-2 variants EG.5 and BA.2.86

2023 · Dana Ashoor, M-Dahmani Fathallah · Preprints.org

Production of Recombinant Human EGFR CR2 Domain and Generation of Monoclonal Antibodies Discriminating The R and K Variants.

2021 · Maryam Marzouq, Amal Alshammary, et al. · Research Square

Works count: 16

Citation count: 41

H-index: 3

I10-index: 2